美国 · SEC FORM 4
Akari Therapeutics Plc
AKTX · Nasdaq · CIK 0001541157 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
29 同一窗口内观察到的 Form 4 交易行
0 sales · 29 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-25 · Gaslightwala Abizer.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -18.0%
- 3M
- -23.7%
- 6M
- +86.1%
- 12M
- —
波动率与流动性
- 波动率
- 293.3%
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- -61.1%
- 细分行业
- Biotechnology
市场数据
价格数据截至:2026-10-02 · 价格来源:OpenBB/yfinance · 来自 SEC 申报文件:ROE · 财年截止日:2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 14,529
- 上期报告
- 10,763
- 日均成交量
- 62,368
- 回补天数
- ≤ 1.0
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-08-25 | Gaslightwala Abizer | 买入 (P) | American Depositary Shares representing Ordinary Shares | 3,000 | USD 0.90 | USD 2,700 | SEC 申报 ↗ |
| 2025-08-22 | Gaslightwala Abizer | 买入 (P) | American Depositary Shares representing Ordinary Shares | 8,000 | USD 0.93 | USD 7,440 | SEC 申报 ↗ |
| 2025-08-21 | Gaslightwala Abizer | 买入 (P) | American Depositary Shares representing Ordinary Shares | 10,000 | USD 0.94 | USD 9,400 | SEC 申报 ↗ |
| 2025-06-24 | Gaslightwala Abizer | 买入 (P) | American Depositary Shares representing Ordinary Shares | 5,203 | USD 1.16 | USD 6,035 | SEC 申报 ↗ |
| 2025-06-23 | Gaslightwala Abizer | 买入 (P) | American Depositary Shares representing Ordinary Shares | 943 | USD 1.15 | USD 1,084 | SEC 申报 ↗ |
| 2025-06-20 | Gaslightwala Abizer | 买入 (P) | American Depositary Shares representing Ordinary Shares | 10,000 | USD 1.20 | USD 12,000 | SEC 申报 ↗ |
| 2025-06-17 | Gaslightwala Abizer | 买入 (P) | American Depositary Shares representing Ordinary Shares | 15,000 | USD 1.20 | USD 18,000 | SEC 申报 ↗ |
Form 4 申报证据
32 transaction lines in the latest 365-day window; 71 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Patel Sandip I | 期权行权/转换 (M) | American Depositary Shares representing Ordinary Shares | 10,052 | USD 0.00 | USD 4 | SEC 申报 ↗ |
| 2026-10-14 | Gaslightwala Abizer | 期权行权/转换 (M) | American Depositary Shares representing Ordinary Shares | 27,066 | USD 0.00 | USD 11 | SEC 申报 ↗ |
| 2026-10-14 | Bazemore Robert B | 期权行权/转换 (M) | American Depositary Shares representing Ordinary Shares | 3,866 | USD 0.00 | USD 2 | SEC 申报 ↗ |
展开近期 Form 4 证据 (20 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Patel Sandip I | 期权行权/转换 (M) | American Depositary Shares representing Ordinary Shares | 10,052 | USD 0.00 | USD 4 | SEC 申报 ↗ |
| 2026-10-14 | Gaslightwala Abizer | 期权行权/转换 (M) | American Depositary Shares representing Ordinary Shares | 27,066 | USD 0.00 | USD 11 | SEC 申报 ↗ |
| 2026-10-14 | Bazemore Robert B | 期权行权/转换 (M) | American Depositary Shares representing Ordinary Shares | 3,866 | USD 0.00 | USD 2 | SEC 申报 ↗ |
| 2026-10-05 | Prudo-Chlebosz Raymond | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 3,240 | USD 7.90 | USD 25,593 | SEC 申报 ↗ |
| 2026-10-05 | Patel Sandip I | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 4,313 | USD 7.90 | USD 34,068 | SEC 申报 ↗ |
| 2026-10-05 | Patel Samir Rashmikant | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 2,236 | USD 7.90 | USD 17,662 | SEC 申报 ↗ |
| 2026-10-05 | Huh Hoyoung | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 6,160 | USD 7.90 | USD 48,658 | SEC 申报 ↗ |
| 2026-10-05 | Bazemore Robert B | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 4,677 | USD 7.90 | USD 36,944 | SEC 申报 ↗ |
| 2026-09-29 | Gaslightwala Abizer | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 6,430 | USD 9.72 | USD 62,500 | SEC 申报 ↗ |
| 2026-08-18 | Prudo-Chlebosz Raymond | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 9,072 | USD 7.90 | USD 71,660 | SEC 申报 ↗ |
| 2026-08-18 | Patel Sandip I | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 12,100 | USD 7.90 | USD 95,578 | SEC 申报 ↗ |
| 2026-08-18 | Patel Samir Rashmikant | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 6,300 | USD 7.90 | USD 49,764 | SEC 申报 ↗ |
| 2026-08-18 | Huh Hoyoung | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 17,249 | USD 7.90 | USD 136,250 | SEC 申报 ↗ |
| 2026-08-18 | Bazemore Robert B | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 13,100 | USD 7.90 | USD 103,477 | SEC 申报 ↗ |
| 2026-08-17 | Farag Kameel D. | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 1,728 | USD 7.52 | USD 12,995 | SEC 申报 ↗ |
| 2026-07-16 | Farag Kameel D. | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 1,130 | USD 11.50 | USD 12,995 | SEC 申报 ↗ |
| 2026-07-07 | Patel Samir Rashmikant | 期权行权/转换 (M) | American Depositary Shares representing Ordinary Shares | 22,474 | USD 0.43 | USD 9,672 | SEC 申报 ↗ |
| 2026-06-24 | Farag Kameel D. | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 18,830 | USD 5.58 | USD 105,006 | SEC 申报 ↗ |
| 2025-11-01 | Farag Kameel D. | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 58,619 | USD 0.75 | USD 43,964 | SEC 申报 ↗ |
| 2025-10-22 | Farag Kameel D. | 奖励/授予 (A) | American Depositary Shares representing Ordinary Shares | 6,277 | USD 0.74 | USD 4,645 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | AKTX |
| CIK | 0001541157 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 71 transaction lines from 2024-04-26 to 2026-10-14 7 P purchase lines · 0 S sale lines · 64 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.